29535831|t|Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier.
29535831|a|Blood-spinal cord barrier (BSCB) alterations, including capillary rupture, have been demonstrated in animal models of amyotrophic lateral sclerosis (ALS) and ALS patients. To date, treatment to restore BSCB in ALS is underexplored. Here, we evaluated whether intravenous transplantation of human bone marrow CD34+ (hBM34+) cells into symptomatic ALS mice leads to restoration of capillary integrity in the spinal cord as determined by detection of microhemorrhages. Three different doses of hBM34+ cells (5 x 104, 5 x 105 or 1 x 106) or media were intravenously injected into symptomatic G93A SOD1 mice at 13 weeks of age. Microhemorrhages were determined in the cervical and lumbar spinal cords of mice at 4 weeks post-treatment, as revealed by Perls' Prussian blue staining for ferric iron. Numerous microhemorrhages were observed in the gray and white matter of the spinal cords in media-treated mice, with a greater number of capillary ruptures within the ventral horn of both segments. In cell-treated mice, microhemorrhage numbers in the cervical and lumbar spinal cords were inversely related to administered cell doses. In particular, the pervasive microvascular ruptures determined in the spinal cords in late symptomatic ALS mice were significantly decreased by the highest cell dose, suggestive of BSCB repair by grafted hBM34+ cells. The study results provide translational outcomes supporting transplantation of hBM34+ cells at an optimal dose as a potential therapeutic strategy for BSCB repair in ALS patients.
29535831	13	29	microhemorrhages	Disease	
29535831	64	67	ALS	Disease	MESH:D000690
29535831	68	72	mice	Species	10090
29535831	91	96	human	Species	9606
29535831	306	335	amyotrophic lateral sclerosis	Disease	MESH:D000690
29535831	337	340	ALS	Disease	MESH:D000690
29535831	346	349	ALS	Disease	MESH:D000690
29535831	350	358	patients	Species	9606
29535831	398	401	ALS	Disease	MESH:D000690
29535831	478	483	human	Species	9606
29535831	496	500	CD34	Gene	947
29535831	534	537	ALS	Disease	MESH:D000690
29535831	538	542	mice	Species	10090
29535831	636	652	microhemorrhages	Disease	
29535831	776	780	G93A	ProteinMutation	tmVar:p|SUB|G|93|A;HGVS:p.G93A;VariantGroup:0;OriginalGene:20655;CorrespondingGene:6647;RS#:121912438;CorrespondingSpecies:10090;CA#:257327
29535831	781	785	SOD1	Gene	20655
29535831	786	790	mice	Species	10090
29535831	811	827	Microhemorrhages	Disease	
29535831	887	891	mice	Species	10090
29535831	941	954	Prussian blue	Chemical	MESH:C000170
29535831	968	979	ferric iron	Chemical	-
29535831	990	1006	microhemorrhages	Disease	
29535831	1087	1091	mice	Species	10090
29535831	1195	1199	mice	Species	10090
29535831	1201	1216	microhemorrhage	Disease	
29535831	1345	1367	microvascular ruptures	Disease	MESH:D012421
29535831	1419	1422	ALS	Disease	MESH:D000690
29535831	1423	1427	mice	Species	10090
29535831	1613	1618	hBM34	CellLine	CVCL:J663
29535831	1700	1703	ALS	Disease	MESH:D000690
29535831	1704	1712	patients	Species	9606

